Audited Results of Solara Active Pharma Sciences Ltd. Company

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Income	1,368.98	1,283.76	1,288.92	1,443.81	1,268.34
Manufacturing Expenses	0	90.87	122.56	107.95	92.12
Personnel Expenses	219.20	211.68	243.92	228.05	234.20
Selling Expenses	0	0	0	0	0
Administrative Expenses	278.59	131.70	178.98	160.55	180.35
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	1,182.30	1,079.92	1,383.98	1,309.77	1,187.99
Operating Profit	186.68	203.84	-95.06	134.04	80.35
Other Recurring Income	5.89	9.14	5.37	22.14	18.76
Adjusted PBDIT	192.57	212.98	-89.69	156.18	99.11
Financial Expenses	94.24	114.81	105.97	90.06	75.27
Depreciation	99.68	99.25	103.03	110.90	112.01
Other Write offs	0	0	0	0	0
Adjusted PBT	-1.35	-1.08	-298.69	-44.78	-88.17
Tax Charges	0	0	78.54	-22.57	-33.10
Adjusted PAT	-1.35	-1.08	-377.23	-22.21	-55.07
Non Recurring Items	-5.89	1.06	-189.08	-1.76	-1.48
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	-7.24	-1.08	-566.87	-22.21	-58.56
Equity Dividend	0	0	0	0	10.78
Preference Dividend	0	0	0	0	0
Retained Earnings	-7.24	-316.29	-316.27	250.04	274.01

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article